Valuation: Orthofix International NV

Market Cap 468M 409M 377M 348M 656M 45.08B 670M 4.51B 1.77B 22.08B 1.76B 1.72B 76B P/E 2026 *
-9.86x
P/E 2027 * -13.1x
Enterprise Value 468M 409M 377M 348M 656M 45.08B 670M 4.51B 1.77B 22.08B 1.76B 1.72B 76B EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.53x
Free-Float
97.81%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-07
Director of Finance/CFO 55 2024-01-14
Compliance Officer - 2015-01-31
Director TitleAgeSince
Director/Board Member 66 2016-03-15
Director/Board Member 54 2020-06-07
Director/Board Member 64 2023-01-04
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+0.91% - - 481M
+1.87%+6.65%-23.58%-6.72% 172B
-0.43%+0.98%-7.33%-5.08% 107B
-0.03%+1.80%+3.38%+60.85% 59.92B
-1.10%+4.85%-11.28%-39.02% 44.07B
-3.21%-2.59% - - 34.76B
-1.71%+4.97%-8.89%-44.18% 30.09B
-1.16%+0.16%+59.66%-6.98% 25.61B
-0.91%+3.40%-4.45%-19.40% 20.86B
-1.49%+0.85%-4.30%-4.91% 21.55B
Average -0.68%+3.27%+0.40%-8.18% 57.33B
Weighted average by Cap. -0.03%+3.37%-8.44%-3.72%

Financials

2026 *2027 *
Net sales 843M 737M 680M 627M 1.18B 81.21B 1.21B 8.13B 3.2B 39.77B 3.17B 3.1B 137B 886M 774M 714M 658M 1.24B 85.29B 1.27B 8.54B 3.36B 41.77B 3.33B 3.25B 144B
Net income -46.32M -40.48M -37.35M -34.43M -64.89M -4.46B -66.33M -446M -176M -2.18B -174M -170M -7.52B -36.85M -32.2M -29.72M -27.39M -51.63M -3.55B -52.77M -355M -140M -1.74B -138M -135M -5.98B
Net Debt - -
Logo Orthofix International NV
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-